c

JAMA Oncology : HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Interview with Nima Sharifi, M.D., author of HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer







c

JAMA Internal Medicine : Evaluation of Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With MDROs

Interview with Christina Vandenbroucke-Grauls, MD, PhD, author of Evaluation of the Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With Multidrug-Resistant Microorganisms: A Systematic Review and Meta-analysis, and Todd Campbell Lee, MD MPH, author of Deprescribing Proton Pump Inhibitors: Overcoming Resistance
















c

JAMA Otolaryngology–Head & Neck Surgery : Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic

Interview with Joshua K Tay, author of Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak, and Babak Givi, MD, author of Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic














c

Athletics | JSW CEO looks at the positives

Athletes at the Inspire Institute of Sports in Vijayanagar have been continuing to train, though with restrictions.




c

Focus on effective surveillance of COVID-19, contact-tracing and early diagnosis: Harsh Vardhan tells Tamil Nadu, Telangana and Karnataka

The Minister also asked the States to ensure adoption of infection, prevention and control (IPC) practices in all health-care settings to avoid and reduce chances of infections to health-care workers.




c

Covid-19 impact: No comfort in hotel stocks as recovery pushed to FY23

Expectations of a slow recovery, high fixed costs and debt worries are putting off investors




c

Inflows in equity mutual funds plunge 25% to Rs 83,781 cr in FY20

This was the sixth successive year of net inflows in equity mutual funds




c

Pullback on the higher side likely if Nifty holds 9,100: Anand Rathi

The broader structure of Nifty still looks weak though




c

Bull Spread strategy on Tata Consumer by Nandish Shah of HDFC Securities

Primary trend of the stock is positive where stock price is trading above its 200-day SMA




c

Stocks to watch: RIL, Tata Motors, RBL Bk, Adani Gas, SBI Cards, SKF India

Here's a look at the top stocks that may remain in focus today




c

Dr Reddy's hits 52-week high after USFDA issues EIR for Srikakulam facility

The company said, with this, all facilities under warning letter are now determined as Voluntary Action Indicated (VAI)




c

HUL surges 4% after Societe Generale buys 129 million shares via bulk deal

On Thursday, UK-based Glaxo-SmithKline (GSK) offloaded its stake in HUL via block deals.




c

RBL Bank declines 12% from day's high in a firm market post Q4 results

The bank's total revenue jumped 33 per cent YoY to Rs 1,522 crore from Rs 1,148 crore reported in Q4FY19, while its net interest income came in at Rs 1,021 crore, up 38 per cent YoY from Rs 739 crore




c

Hindalco gains 5% after unit Novelis' Q4 results; brokerages maintain 'buy'

Novelis informed that its net income attributable to its common shareholder came in at $63 million for the quarter under review, down 39 per cent year-on-year (YoY




c

Tech-related firms in focus; PPFAS adds Microsoft to portfolio in April

Microsoft is one of the leaders in the cloud computing segment segment, besides Alphabet (Google) and Amazon, making the stock attractive




c

Laurus Labs under pressure, plunges 10% after multiple block deals

Till 12:44 pm, a combined 34.4 million equity shares, representing 32.2 per cent of total equity of Laurus Labs, changed hands on the BSE and NSE.




c

Cyient locked in 10% lower circuit on lower-than-expected Q4 results

The company's March quarter (Q4F20) performance came below expectations on, both, revenue and margin terms largely due to the impact of Covid-19.




c

Equity flows dip 47% in Apr despite mkts seeing sharpest run-up since 2009

Debt categories continued to see redemptions. Credit risk funds saw a bulk of the outflows at Rs 19,238 crore, registering the worst month for the category in 13 months




c

RIL, Infosys, HUL account for 51% recovery in Sensex from 52-week low

In all, these three entities have added Rs 5.8 trillion to their m-cap during the period, against a Rs 11.3-trillion rise in the incremental m-cap of all 30 Sensex companies




c

Bitcoin 'halving' to shore up market value with steady demand: Experts

The previous events fueled huge rallies in bitcoin's market value, but there is a wildcard this time in the form of the coronavirus pandemic, some analysts said.




c

Risk-averse investors re-deploy funds in arbitrage MF schemes in April

Aversion to debt products has contributed to renewed interest in the category